1-3 of 3
Lukas Heukamp
Close
Sort by
Journal Articles

Impact of Somatic Mutations on Outcome in Patients > 60 Years Old with Newly Diagnosed AML Treated with Response-Adapted Sequential Azacitidine and Induction Chemotherapy within the DRKS00004519 Trial (RAS-AZIC) of the East German Study Group of Hematology and Oncology (OSHO)

Nadja Jaekel, Susann Schulze, MD, Udo Siebolts, MD, Anja Haak, PhD, Nikolaos Pazaitis, MD, Michael Cross, PhD, Dietger Niederwieser, MD, Mathias Hänel, MD, Georg Maschmeyer, MD, Maxi Wass, MD, Lukas Heukamp, MB PhD, Roopika Menon, Miriam Bertrand, Claudia Wickenhauser, MD, Oana Brosteanu, PhD, Haifa Kathrin Al-Ali, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1420.
https://doi.org/10.1182/blood-2019-127865
Published: 2019
Journal Articles

CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia

Oleg Fedorchenko, Marius Stiefelhagen, Abdul A. Peer-Zada, Romy Barthel, Petra Mayer, Laura Eckei, Alexandra Breuer, Giuliano Crispatzu, Natascha Rosen, Thomas Landwehr, Nils Lilienthal, Michael Möllmann, Manuel Montesinos-Rongen, Lukas Heukamp, Jan Dürig, Michael Hallek, Günter Fingerle-Rowson, Marco Herling
Journal: Blood
Blood (2013) 121 (20): 4126–4136.
https://doi.org/10.1182/blood-2012-11-466250
Published: 2013
Includes: Supplemental data
Journal Articles

Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor

Nina Reinart, Phuong-Hien Nguyen, Jorge Boucas, Natascha Rosen, Hans-Michael Kvasnicka, Lukas Heukamp, Cornelia Rudolph, Vangica Ristovska, Tanja Velmans, Carolin Mueller, Katrin S. Reiners, Elke Pogge von Strandmann, Günter Krause, Manuel Montesinos-Rongen, Brigitte Schlegelberger, Marco Herling, Michael Hallek, Günter Fingerle-Rowson
Journal: Blood
Blood (2013) 121 (5): 812–821.
https://doi.org/10.1182/blood-2012-05-431452
Published: 2013
Includes: Supplemental data